For citations:
Shinkin K.D., Krivoshchekov S.V., Bondarev A.A., Bykov V.V., Kaminsky I.P., Knyazev A.S., Belousov M.V. Development and validation of an analytical method for the quantitative determination of 2-[2-[(5RS)-5-(hydroxymethyl)-3-methyl-1,3-oxazolidin-2-ylidene]-2-cyanoethylidene]-1H-indol-3(2H)-one in the medicinal product by HPLC-DAD. Drug development & registration. (In Russ.) https://doi.org/10.33380/2305-2066-2026-15-4-2335
JATS XML
Email this article 
